Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 4;99(49):e23297.
doi: 10.1097/MD.0000000000023297.

Proton pump inhibitors for the treatment of laryngopharyngeal reflux disease: A protocol for systematic review and meta-analysis

Xiangyi Liu  1   2 , Ying Jiang  2 , Haiyan Luo  2 , Haolin Liu  3
Affiliations

Proton pump inhibitors for the treatment of laryngopharyngeal reflux disease: A protocol for systematic review and meta-analysis

Xiangyi Liu et al. Medicine (Baltimore). .

Abstract

Background: Laryngopharyngeal Reflux disease refers to abnormal reflux of gastric contents through the esophagus into the throat, which irritates and damages the pharyngeal mucosa, and causes corresponding symptoms. Proton Pump Inhibitors are an important class of gastric acid secretion inhibitors after H2 receptor blockers, which can be used clinically to treat peptic ulcer, abnormal gastric acid secretion and other related diseases. The common clinical drugs include omeprazole, lansoprazole, rabeprazole and so on. Clinical practice has shown that Proton Pump Inhibitors have a good therapeutic effect on Laryngopharyngeal Reflux disease, but evidence of evidence-based medicine is lacking. The purpose of this protocol is to systematically evaluate the efficacy and safety of Proton Pump Inhibitors in the treatment of Laryngopharyngeal Reflux disease and to improve the evidence-based basis for the clinical application of Proton Pump Inhibitors in the treatment of Laryngopharyngeal Reflux disease.

Methods: English computer retrieval database (PubMed, Embase, Web of Science, the Cochrane Library) and Chinese computer retrieval database (Wanfang Database, VIP Information Chinese Journal Service Platform, Chinese Biomedical Database) . In addition, Baidu Scholar and Google Scholar were manually searched for randomized controlled clinical studies on the treatment of laryngeal reflux disease with Proton Pump Inhibitors from the establishment of the database to July 2020. Two researchers independently extracted and evaluated the data of the included studies, and meta-analysis was conducted on the included literatures with RevMan5.3 software without language restrictions.

Results: In this study, the efficacy and safety of Proton Pump Inhibitors in the treatment of Laryngopharyngeal Reflux disease are evaluated by the overall response rate, clinical symptom remission rate and other indicators.

Conclusions: This study will provide reliable evidence-based evidence for the clinical application of Proton Pump Inhibitors in the treatment of Laryngopharyngeal Reflux disease.OSF Registration number: DOI 10.17605 / OSF.IO / NY6SC.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
The process of literature filtering.
See this image and copyright information in PMC

References

    1. Hutnik R, Zlatopolsky A, Mehraban-Far S, et al. Laryngopharyngeal reflux: comparing improvements in reflux symptom index with reflux finding score. Am J Otolaryngol 2020;41:102730. - PubMed
    1. Caparroz F, Campanholo M, Regina C, et al. Clinical and polysomnographic predictors of Laryngopharyngeal Reflux in obstructive sleep apnea syndrome. Brazilian J otorhinolaryngol 2019;85:408–15. - PMC - PubMed
    1. Wang H-Y, Wang S-C, Teng B, et al. Research progress on the relationship between obstructive sleep apnea syndrome and laryngopharyngeal reflux disease. Journal of ear, nose, throat and ophthalmology, Shandong university 2020;34:134–8.
    1. Li C, Zhang L, Wang W, et al. The prevalence and relationship between laryngopharyngeal reflux disease, anxiety and depression in otolaryngology outpatients. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2020;55:241–8. - PubMed
    1. Min C, Park B, Sim S, et al. Dietary modification for laryngopharyngeal reflux: systematic review. The Journal of laryngology otology 2019;133:80–6. - PubMed

MeSH terms

Substances